JC Medical, Inc. has announced the treatment of the first patient with the company’s Transfemoral TAVI device, the J-Valve TF System for aortic regurgitation. The first patient was treated at St. Paul’s Hospital – Vancouver, Canada by John Webb, MD, FACC, FSCAI, Director of Interventional Cardiology. There are currently no transcatheter valves approved for the treatment of pure aortic regurgitation in the U.S., Canada, or Europe...